ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,682.95
      0.30%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      06/01/20248:30AMPR Newswire (Canada)Message from the Governor General on National Indigenous History Month
      06/01/20248:30AMPR Newswire (US)Xtalks Announces its Life Science Webinar Calendar for June 2024
      06/01/20248:30AMPR Newswire (Canada)Message de la gouverneure générale à l'occasion du Mois national de l'histoire autochtone
      06/01/20248:15AMGlobeNewswire Inc.Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
      06/01/20248:10AMBusiness WireNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual MeetingNYSE:NUVBPanacea Acquisition Corp
      06/01/20248:05AMGlobeNewswire Inc.Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
      06/01/20248:05AMPR Newswire (US)Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:TGRTirupati Graphite Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:TPXTpximpact Holdings Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:PIERBrighton Pier Group Plc (the)
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:LPALpa Group Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:PINEPinewood Technologies Group Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:PYCPhysiomics Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:TAVITavistock Investments Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:RTOPRegtech Open Project Plc
      06/01/20248:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:RTOPRegtech Open Project Plc
      06/01/20248:00AMBusiness WireMassive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
      06/01/20248:00AMGlobeNewswire Inc.Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024NASDAQ:MOLNMolecular Partners AG
      06/01/20248:00AMGlobeNewswire Inc.CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
      06/01/20248:00AMBusiness WirePfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)NYSE:PFEPfizer Inc
      06/01/20248:00AMBusiness WireKRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung CancerNYSE:BMYBristol Myers Squibb Co
      06/01/20248:00AMBusiness WireGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI CancersNYSE:RCUSArcus Biosciences Inc
      06/01/20248:00AMGlobeNewswire Inc.Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual MeetingNASDAQ:KYMRKymera Therapeutics Inc
      06/01/20248:00AMBusiness WireTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaNYSE:PFEPfizer Inc
      06/01/20248:00AMBusiness WireIvonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMANASDAQ:SMMTSummit Therapeutics Inc
      06/01/20248:00AMBusiness WireGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI CancersNYSE:RCUSArcus Biosciences Inc
      06/01/20248:00AMBusiness WireAccutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
      06/01/20248:00AMGlobeNewswire Inc.OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
      06/01/20248:00AMBusiness WireGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI CancersNASDAQ:GILDGilead Sciences Inc
      06/01/20248:00AMGlobeNewswire Inc.Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic CancerNASDAQ:PPBTPurple Biotech Ltd